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The Complex Surgical Management of the First Case of Severe 
Combined Immunodeficiency and Multiple Intestinal Atresias 
Surviving after the Fourth Year of Life
Riccardo Guanà, Salvatore Garofano, Elisabetta Teruzzi, Simona Vinardi, Giulia Carbonaro, 
Alessia Cerrina, Isabella Morra*, Davide Montin†, Alessandro Mussa† and Jürgen Schleef
Divisions of Pediatric General Surgery and *Pathology, †Department of Pediatric and Public Health Sciences, University 
of Torino, Regina Margherita Children’s Hospital, Torino, Italy
Severe combined immunodeficiency (SCID) is a life-threatening syndrome of recurrent infections and gastro-
intestinal alterations due to severe compromise of T cells and B cells. Clinically, most patients present symptoms 
before the age of 3 months and without intervention SCID usually results in severe infections and death by the age 
of 2 years. Its association with intestinal anomalies as multiple intestinal atresias (MIA) is rare and worsens the prog-
nosis, resulting lethal. We describe the case of a four year-old boy with SCID-MIA. He presented at birth with meco-
nium peritonitis, multiple ileal atresias and underwent several intestinal resections.  A targeted Sanger sequencing 
revealed a homozygous 4-bp deletion (c.313ΔTATC; p.Y105fs) in tetratricopeptide repeat domain 7A (TTC7A).
He experienced surgical procedures including  resection and stricturoplasty. Despite parenteral  nutrition-associated 
liver disease, the patient is surviving at the time of writing the report.  Precocious immune system assessment, scrutiny 
of TTC7A mutations and prompt surgical procedures are crucial in the management.
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INTRODUCTION
　Severe combined immunodeficiency with multi-
ple intestinal atresias (SCID-MIA) is an extremely 
rare hereditary disease characterized by intestinal 
obstructions and life-threatening immune system 
defects involving both humoral and cellular immune 
systems. The genetic bases of SCID-MIA have been 
recently unravelled by Samuels et al. [1]: exome se-
quencing experiments demonstrated that the dis-
ease is caused by inactivating autosomal recessive 
mutation in the tetratricopeptide repeat domain 7A 
(TTC7A) gene, coding for a protein expressed in both 
thymic epithelial cells and thymocytes. TTC7A in-
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Fig. 1. Intra-operative findings
at the time of the first lapa-
rotomy and intestinal reco-
nstruction.
activation lead to severe lymphoid depletion in the 
thymus and peripheral lymphoid tissues from pa-
tients with SCID-MIA. Loss-of- function mutation in 
TTC7A was also associated with very early onset in-
flammatory bowel diseases [2]. Functional studies 
demonstrated that the mutations cause defects in 
enterocytes and T cells that lead to severe apoptotic 
enterocolitis, with or without immunodeficiency 
[2]. Study by Chen et al. [3] confirmed these ob-
servations in eight unrelated cases.
　Our report describes the long and difficult ther-
apeutic management of one patient among these 
eight that to our knowledge nowadays is the lon-
gest-surviving.
CASE REPORT
　The patient was admitted to our hospital at birth, 
on July 2010, with diagnosis of abdominal distension 
and respiratory failure. The baby was born to parents 
of Bosnian origin, from elective caesarean section at 
the 34th week of gestation, with 2.710 g neonatal 
weight, 45 cm length, 32.4 cm head circumference, 
and 5/8 Apgar score at 1 and 5 minutes, respectively. 
His general condition at birth was poor and the baby 
underwent nasotracheal intubation. At a prenatal ul-
trasonography, intestinal perforation consistent with 
duodenal or jejunal atresia associated with poly-
hydramnios was suspected. At birth an echocardiog-
raphy demonstrated a patent arterial duct with bidir-
ectional shunting and patent foramen ovale with a 
negligible left to right shunt. Abdominal X-ray evi-
denced a clear-cut gastric air bubble, but absence of 
intestinal gas in all remaining abdominal fields in-
dicating duodenal or jejunal atresia. On an emergent 
laparotomy, meconium peritonitis due to intestinal 
perforation was accompanied by 16 intestinal lesions 
of intestinal atresias and severe stenosis with in-
testinal malrotation. These traits were distanced by 
minimum of 3 cm and maximum of 15 cm. The sole 
trait without stenosis was the first jejunal loop. In ad-
dition, cecal atresia was present (Fig. 1). Serials of re-
section and anastomosis on three loci of ileal atresia 
(each one of 6, 8, and 11 cm) followed by five ileal 
strictureplasties were performed. Also, colic atresia 
and ileocecal atresia were treated with an “en bloc” re-
section, including cecal appendix, using a gastro-in-
testinal anastomosis stapler and creating an ileo-colic 
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Table 1. Immunological Features at 10 Months of Age
Parameter Patient Normal range
Lymphocytes (cells/μL)
CD3+ (cells/μL)
CD4+ (cells/μL)
CD8+ (cells/μL)
CD19+ (cells/μL)
CD16/56+ (cells/μL)
RTE (CD4+45RA+31+ cells/μL)
Proliferation to PHA (SI)
IgG (mg/dL)
IgA (mg/dL)
IgM (mg/dL)
620
169
135
17
2
312
35
1
57
＜6
＜25
4,000-6,100
2,400-3,300
1,600-2,200
820-1,600
1,000-1,600
270-1,100
800-4,000
＞67
223-1,099
0-73
0-100
RTE: recent thymic emigrants lymphocytes, PHA: phytohemag-
glutinin, SI: stimulation index, Ig: immunoglobulin.
termino-lateral anastomosis. A colostomy at the de-
scending colon was followed due to additional atresia 
at descending and sigmoid colons. The remaining 
ileum was estimated to be approximately 70 cm long. 
Histopathological examination showed the classic as-
pect of intestinal lumen fibrosis. In the post-operative 
period, parenteral nutrition (PN) was established 
through a central venous catheter. On August 2010 
bowel obstruction due to multiple adhesions neces-
sitated treatment with intestinal anastomosis. At the 
second laparotomy, tenacious adhesions were present 
between ileal loops and the caudate lobe of the liver 
that caused an obstruction of the pyloric region. 
Adhesiolysis of all adhesions was performed. On 
September 2010, a further episode of bowel ob-
struction occurred. At the laparotomy, tenacious ad-
hesions that compacted all the intestinal loops to 
form a rigid coil were present and adhesiolysis on 
each lesion was performed. A CoSeal surgical sealant 
(Baxter Healthcare Corporation, Deerfield, IL, USA) 
was applied on the intestinal loop at the end of the op-
eration for prevent spontaneous intestinal adhesion. 
On September 2010, we positioned a permanent cen-
tral venous catheter in the left subclavian vein for 
long term PN. On March 2011, peritoneal adhesiolysis 
was necessary for a newly developed bowel occlusion. 
The lysis of adhesions allowed the highlighting of a 
discrete maturation of the intestine in terms of size 
and length as well as the presence of numerous ileal 
stenotic areas. Performing of seven enteroplasties in 
Heineke-Mikulizt fashion was done in corre-
spondence at the ileal stenotic traits. We also posi-
tioned naso-jejunal two-way polyurethane enteral 
tube. On March 2011, dehiscence of the surgical 
wound occurred. Wound revision and closure with in-
terposition of mesh was necessary. Due to infection 
on the abdominal wall prosthetic patch, on April 
2011, it was necessary to remove the device from the 
abdomen and to close the abdominal wound. During 
the operation, under fluoroscopic control, Iomeron 
(Bracco Imaging SpA, Milano, Italy) was adminis-
tered through the stoma, allowing the highlighting of 
a complete channeling of the intestine up to the duo-
denum and the absence spillage of the contrast agent. 
A radiographic intestinal transit was completed, ad-
ministering contrast material through the nasogastric 
tube allowing an assessment of the patency of stom-
ach, duodenum and remaining trait of the bowel. 
　The clinical course was complicated by multiple epi-
sodes of sepsis caused by Pseudomonas aeruginosa, one 
with the development of an abdominal abscess, and 
Candida albicans. Laboratory investigations at the age  
of ten months showed severe T- and B-cell lymphope-
nia, absent proliferation to phytohemagglutinin and 
anti-CD3, and profound hypogammaglobulinemia 
(the nadir value of serum levels of immunoglobulin 
(Ig) G was 57, IgA and IgM values were undetectable), 
confirming the diagnosis of SCID (Table 1). Anti-fun-
gal, anti-viral and anti-bacterial prophylaxes were 
started, together with regular intravenous immu-
noglobulin replacement therapy.
　Whole-exome sequencing was performed on the 
patient and healthy family members. The analysis on 
the patient identified a novel deleterious variant in 
the gene TTC7A. Sanger sequencing to validate the 
deleterious variant was performed and revealed a ho-
mozygous 4-bp deletion (c.313ΔTATC) in exon 2 of 
TTC7A (Fig. 2). Therefore, the variant is predicted to 
lead to a frameshift mutation at codon 105 (p.Y105fs) 
and subsequent nonsense-mediated decay of the re-
sulting ribonucleic acid transcript, which means the 
strong possibility of SCID-MIA.
　The deletion was also present in the parents but 
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Fig. 2. Sanger sequencing revealed a homozygous 4-bp deletion
(c.313ΔTATC) in exon 2 of TTC7A.
Fig. 4. Magnetic resonance 
enterography at 3 years of 
age, evidencing absence of 
intestinal stenosis or dilation 
(A) and progressive develop-
ment and growth of the gut
(B).
Fig. 3. Barium follow-through
x-ray via gastrostomy and 
colostomy at 2 years of age, 
demonstrating patency of the 
gut lumen (A) and a satis-
factory intestinal maturation 
(B).
with a heterozygote mutation and no anomaly was 
found in the brothers.
　A multidisciplinary team meeting involving im-
munologist, infectious disease specialist, anaesthesi-
ologist, pediatric surgeon and social worker was 
organized. The team explained to the parents the 
poor prognosis of their baby, and it was decided to 
proceed with only supportive therapies.
　A percutaneous endoscopic gastrostomy was per-
formed on September 2011 in order to decompress the 
stomach and small bowel and to avoid the discomfort 
of the nasogastric tube. In the following months the 
clinical improvement of the patient allowed a pro-
tected hospital discharge. The patient was discharged 
on May 2012 and followed-up monthly. His therapy 
consisted of acyclovir, fluconazole, antibiotic prophy-
laxis administered daily, and immunoglobulin re-
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placement (400 mg/kg) every 21 days.
　Barium follow-through x-ray via gastrostomy and 
colostomy at two years of age and magnetic resonance 
enterography at three years of age, demonstrated pa-
tency of the gut lumen and a satisfactory intestinal 
maturation (Fig. 3 and 4). Nevertheless, his intestines 
do not demonstrate adequate spontaneous motility to 
allow surgical recanalization in a short time, and so he 
lived in a status of persistent gastrointestinal sub-oc-
clusion requiring continuously home PN with the im-
possibility to supply some feeding regimens via the 
gastrostomy tube.
　In the last year the patient experienced three hos-
pitalization, each one for a two-weeks period, pre-
senting recurrent episodes of pancreatitis.
　His neurological development and stature growth 
were impaired (height below the fifth percentile), 
but in slow progression. PN-associated liver disease 
was worsening progressively.
　On October 2013, a multidisciplinary committee, 
excluded the possibility of a combined transpla-
ntation of liver and intestine due to the high risk of 
an aggressive form of graft-versus-host disease post- 
transplant [4].
DISCUSSION
　Patients with SCID have recurrent and severe in-
fections; most of these are bloodstream infections 
caused by intestinal bacteria, probably consequent to 
abnormalities of the gut barrier consistent with 
SCID-MIA.
　Usually these patients are not able to receive en-
teral feeding, remain dependent on PN, have re-
peated episodes of sepsis, and die after a difficult ne-
onatal intensive care course.
　In our case, the patient suffering from a form of 
SCID with phenotype T-B-NK+, an early adminis-
tered intravenous immunoglobulin replacement 
therapy and a most conservative resective intestinal 
surgery contributed to patient’s survival, in spite of a 
persistent intestinal subocclusion status, recurrent 
episodes of pancreatitis and a progressive hepatopathy.
　In these patients mutations of the TTC7A gene af-
fect immune system development and function 
causing the association between SCID and MIA.
　Most patients with SCID-MIA die early in life, and 
there is very limited experience with attempts to 
achieve systemic immunity in these cases. Few expe-
riences were reported with HLA-matched cord blood 
transplantation [5]. Hematopoietic cell transplan-
tation (HCT) from a matched unrelated donor with 
or without preparative chemotherapy with cyclo-
phosphamide and thiotepa has also been attempted.
　However, although the presence of T cells with a 
naive phenotype suggests effective de novo thymo-
poiesis, longer follow-up studies will be needed to 
confirm the efficacy of HCT [6]. 
　Donor-derived, partial immune reconstitution has 
been observed after combined liver and small bowel 
transplantation in infants with SCID-MIA [7]. In 
2004, Gilroy et al. [8] described donor immune re-
constitution after a liver-small bowel trans-
plantation for multiple intestinal atresia with 
immunodeficiency. At sixteen months of age, a child 
with SCID-MIA underwent liver-small bowel trans-
plantation from a 1-of-6 HLA-matched donor. He 
achieved complete enteral autonomy and normal liv-
er function and has never shown evidence of allog-
raft rejection two years post-transplant. Laboratory 
studies revealed that more than 99% of his 
CD3-positive lymphocytes and 50% of his CD19-pos-
itive lymphocytes were of donor origin, whereas 
granulocytes and monocytes remained of recipient 
origin. He synthesizes polyclonal IgG, IgA, and IgM. 
The authors postulated that he has engrafted a donor 
intestine-derived immune system and is incapable of 
rejecting his engrafted organs.
　Recently, Agarwal et al. [9] presented the clinical 
progress of a five year-old infant with multiple in-
testinal atresia and combined immunodeficiency 
who carries novel compound heterozygote muta-
tions in TTC7A gene.
　In conclusion, mutations in TTC7A should be scru-
tinized in patients with SCID-MIA. Characterization 
of the role of this protein in the immune system and 
intestinal development, as well as in thymic epi-
thelial cells, might have important therapeutic im-
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plications in the future in SCID-MIA patients. On the 
other hand, SCID treatment will not provide solution 
to MIA. 
　The management of the latter will still be of surgi-
cal pertinency and surgeons must be prepared to face 
a broad spectrum of abdominal complications.
　Precocious assessment of the immune system, 
scrutiny of TTC7A mutations and prompt surgical 
procedures are crucial in the management these 
patients.
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